Suppr超能文献

体内大鼠心脏中α1-肾上腺素能受体的刺激及蛋白激酶C介导的ecto-5'-核苷酸酶激活

Stimulation of alpha 1-adrenoceptors and protein kinase C-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo.

作者信息

Sato T, Obata T, Yamanaka Y, Arita M

机构信息

Department of Physiology, Oita Medical University, Japan.

出版信息

J Physiol. 1997 Aug 15;503 ( Pt 1)(Pt 1):119-27. doi: 10.1111/j.1469-7793.1997.119bi.x.

Abstract
  1. To determine whether protein kinase C (PKC)-mediated activation of ecto-5'-nucleotidase would increase interstitial adenosine concentrations in the rat heart in vivo, we made use of the microdialysis technique and a flexibly mounted probe, which was implanted in the left ventricular myocardium and perfused with Tyrode solution. 2. The baseline level of dialysate adenosine was 0.51 +/- 0.09 microM (n = 16). Perfusion of adenosine 5'-monophosphate (AMP, 100 microM) through the probe increased the dialysate adenosine concentration markedly to 9.25 +/- 0.46 microM (n = 15). alpha, beta-Methyleneadenosine 5'-diphosphate (AOPCP, 100 microM), an inhibitor of ecto-5'-nucleotidase, abolished the AMP-induced increase in dialysate adenosine, but did not affect the baseline level of adenosine. These observations suggest that the dialysate adenosine obtained during the perfusion with AMP, but not the baseline levels of adenosine, originated from the dephosphorylation of AMP by ecto-5'-nucleotidase. Thus, the level of adenosine measured during AMP perfusion gives an index of the activity of ecto-5'-nucleotidase in the tissue. 3. Noradrenaline (10 microM) increased the adenosine concentration measured in the presence of 100 microM AMP (i.e. the activity of ecto-5'-nucleotidase) by 38.7 +/- 9.6% (n = 5, P < 0.05), an increase which was inhibited by an antagonist of the alpha 1-adrenoceptor (prazosin, 50 microM) or of PKC (chelerythrine, 10 microM). Further application of either the alpha 1-adrenoceptor agonist methoxamine (100 microM) or the diacylglycerol analogue 1,2-dioctanoyl-sn-glycerol (DOG, 100 microM) also increased the adenosine concentration by 35.1 +/- 10.0% (n = 6, P < 0.05) or 40.6 +/- 8.3% (n = 5, P < 0.05), respectively. 4. The presence of okadaic acid (50 microM), an inhibitor of protein phosphatase, enhanced the noradrenaline-induced increase in adenosine concentration by 112.4 +/- 35.9% (n = 4, P < 0.05), to a level significantly (P < 0.05) greater than the increase caused by noradrenaline alone (38.7 +/- 9.6%). 5. These data provide the first evidence that alpha 1-adrenoceptor stimulation and the subsequent activation of PKC can increase adenosine concentrations in interstitial spaces of ventricular muscle in vivo, through activation of endogenous ecto-5'-nucleotidase.
摘要
  1. 为了确定蛋白激酶C(PKC)介导的ecto - 5'-核苷酸酶激活是否会增加大鼠心脏体内间质腺苷浓度,我们采用了微透析技术和一个灵活安装的探针,将其植入左心室心肌并用台氏液灌注。2. 透析液腺苷的基线水平为0.51±0.09微摩尔/升(n = 16)。通过探针灌注5'-单磷酸腺苷(AMP,100微摩尔/升)可使透析液腺苷浓度显著增加至9.25±0.46微摩尔/升(n = 15)。ecto - 5'-核苷酸酶抑制剂α,β-亚甲基腺苷5'-二磷酸(AOPCP,100微摩尔/升)可消除AMP诱导的透析液腺苷增加,但不影响腺苷的基线水平。这些观察结果表明,在灌注AMP期间获得的透析液腺苷,而非腺苷的基线水平,源自ecto - 5'-核苷酸酶对AMP的去磷酸化。因此,在AMP灌注期间测量的腺苷水平给出了组织中ecto - 5'-核苷酸酶活性的指标。3. 去甲肾上腺素(10微摩尔/升)使在100微摩尔/升AMP存在下测量的腺苷浓度(即ecto - 5'-核苷酸酶的活性)增加了38.7±9.6%(n = 5,P < 0.05),α1 -肾上腺素能受体拮抗剂(哌唑嗪,50微摩尔/升)或PKC拮抗剂(白屈菜红碱,10微摩尔/升)可抑制这种增加。进一步应用α1 -肾上腺素能受体激动剂甲氧明(100微摩尔/升)或二酰基甘油类似物1,2 -二辛酰基 - sn -甘油(DOG,100微摩尔/升)也分别使腺苷浓度增加了35.1±10.0%(n = 6,P < 0.05)或40.6±8.3%(n = 5,P < 0.05)。4. 蛋白磷酸酶抑制剂冈田酸(50微摩尔/升)的存在使去甲肾上腺素诱导的腺苷浓度增加增强了112.4±35.9%(n = 4,P < 0.05),达到显著高于单独由去甲肾上腺素引起的增加水平(38.7±9.6%,P < 0.05)。5. 这些数据提供了首个证据,即α1 -肾上腺素能受体刺激以及随后PKC的激活可通过激活内源性ecto - 5'-核苷酸酶增加体内心室肌间质空间中的腺苷浓度。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验